Vendor profile Research · US · —

Shanghai Baoju

B+
Composite 8.0 / 10

Last updated 2026-10-05. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
5.9
Fair
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
GHK-Cu
9.5A
9.3 12 — — — — view
Retatrutide
8.8B+
8.5 30 — — — — view
Tirzepatide
8.3B+
7.8 31 — — — — view
Ipamorelin
7.3B
6.6 5 — — — — view
BPC-157
6.3C
5.4 6 — — — — view
Tesamorelin
6.0C
5.0 5 — — — — view
TB-500
4.7D
3.4 4 — — — — view
KPV
2.9E
1.1 3 — — — — view
MOTS-c
—
— 0 — — — — view
PT-141
—
— 0 — — — — view
Semaglutide
—
— 0 — — — — view
Sermorelin
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Shanghai Baoju against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.